XTX Topco’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Buy
41,030
+13,536
+49% +$154K 0.01% 2398
2026
Q1
$313K Sell
27,494
-13,317
-33% -$144K 0.01% 2448
2025
Q4
$524K Buy
40,811
+16,742
+70% +$207K 0.01% 1552
2025
Q3
$269K Buy
+24,069
New +$232K 0.01% 1590
2024
Q4
Sell
-74,816
Closed -$582K 2259
2024
Q3
$582K Buy
+74,816
New +$540K 0.04% 715
2024
Q1
Sell
-83,224
Closed -$652K 1806
2023
Q4
$652K Buy
83,224
+69,531
+508% +$482K 0.14% 131
2023
Q3
$100K Buy
+13,693
New +$114K 0.02% 1186
2023
Q2
Sell
-10,478
Closed -$108K 1392
2023
Q1
$108K Buy
+10,478
New +$134K 0.02% 1085

Other funds holding ANGO

XTX Topco's ANGO Position: Q2 2026 in Review

XTX Topco increased its AngioDynamics (ANGO) stake by 49% in Q2 2026, buying an estimated $154K and bringing the position to 41,030 shares worth $534K. The position accounts for 0.01% of the portfolio, ranked #2398.

XTX Topco first reported a position in ANGO in Q1 2023 and has held it in 8 quarters since. The position peaked at $652K in Q4 2023. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • XTX Topco held 41,030 shares of AngioDynamics worth $534K as of Q2 2026.
  • XTX Topco bought 13,536 AngioDynamics shares in Q2 2026, an estimated $154K.
  • AngioDynamics made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2398 holding.
  • XTX Topco first reported a position in AngioDynamics in Q1 2023 and has held it in 8 quarters since.
  • XTX Topco's AngioDynamics position peaked at $652K in Q4 2023.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.